CytoDyn to Host Investor Webcast on Corporate and Clinical Progress

CytoDyn will host an investor webcast on October 19, 2026, at 1 p.m. PT to provide corporate and clinical updates. The webcast will cover financial progress, 2026 priorities and upcoming milestones. Natera’s Reny Aniline will discuss the strategic collaboration between the companies, including early ctDNA observations from the CLOVER study. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoDyn Inc. published the original content used to generate this news brief via (Ref. ID: 202610150830PRIMZONEFULLFEED9846155) on October 15, 2026, and is solely responsible for the information contained therein. (C)